Glenmede Trust CO Na Clovis Oncology, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $3,383 - $13,216	-861 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $10,013 - $28,128	861 New	861 $15,000
Q3 2018 Nov 15, 2018	SELL	$29.37 - $49.48 $31,719 - $53,438	-1,080 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.06 - $62.4 $43,952 - $65,208	1,045 Added 2985.71%	1,080 $49,000
Q4 2017 Feb 15, 2018	BUY	$57.69 - $84.58 $2,019 - $2,960	35	35 $2,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.